Articles - Tagged as 'to'

Photographic assessment in evaluating clubfoot treatment outcomes - lessons learnt

Assessing barriers to quality trauma care in low and middle-income countries: A Delphi study.

This new study aimed to establish consensus on the most important barriers, within a Three Delays framework, to accessing injury care in Low and Middle Income Countries that should be considered when evaluating a health system.

The global burden of other musculoskeletal disorders: estimates from the Global Burden of Disease 2010 study

Objective: To estimate disability from the remainder of musculoskeletal (MSK) disorders (categorised as other MSK) not covered by the estimates made specifically for osteoarthritis (OA), rheumatoid arthritis (RA), gout, low back pain and neck pain, as part of the Global Burden of Disease (GBD) 2010 study.

The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study

Objective: To estimate the global burden of hip and knee osteoarthritis (OA) as part of the Global Burden of Disease 2010 study and to explore how the burden of hip and knee OA compares with other conditions.

The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study

Objectives: To estimate the global burden of rheumatoid arthritis (RA), as part of the Global Burden of Disease 2010 study of 291 conditions and how the burden of RA compares with other conditions.

The global burden of musculoskeletal conditions for 2010: an overview of methods

The objective of this paper is to provide an overview of methods used for estimating the burden from musculoskeletal (MSK) conditions in the Global Burden of Diseases 2010 study. It should be read in conjunction with the disease-specific MSK papers published in Annals of Rheumatic Diseases.

Epidemiology: Measurement matters—making musculoskeletal disease count

Reliable estimates of disease burden support rational allocation of financial and human resources. Measurement is a powerful force for change as 'what gets measured gets done'. The global burden of musculoskeletal disease studies ensures visibility of these highly prevalent, disabling diseases. Now we must act to reduce disease burden.